Login

John Lai, CEO/President of PetVivo Holdings, Inc., discusses game-changing innovations in a segment interview. 00:10:00

Share On Facebook Share On Twitter

John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Joey Zwillinger on Simplicity & Sustainability: The Allbirds Story | Joey Zwillinger, CEO, Allbirds Inc.
00:10:00
RingCentral CEO Vlad Shmunis discusses the company's new AI product launch.
00:10:00
Space Origins and the Startup Ecosystem|Thomas Gillespie,Managing Partner,In-Q-Tel (IQT)
00:10:00
Interview with Marvin from Mantilla Bioscience at NEBA
00:10:00
Abacus Property Group's Strategic Approach to Real Estate Investment|Steven Sewell, Managing Director,Abacus Property Group
00:10:00
Pfizer
00:10:00
Unscripted Investment Journey: From Beans on Toast to a Lucky Break During the Pandemic|Adam Davis,CEO,Capital 3PM
00:10:00
Behind the Scenes with Matt Roberts: An Exclusive Interview | Matt Roberts, Chief Planning Officer, Financial Planner of Syverson Strege
00:10:00
Exploring St. Augustine's Enduring Influence: Insights from Professor Paig Hawk Child|Paige Hochschild,Professor,Mount St. Mary's University
00:10:00
Lazard: Active Management with Global Reach and Conviction
00:10:00
CTO Chairman at Invest Nest: Unlocking Citigold's Potential | Mr Mark J Lynch – Executive Chairman of Citigold corporation ltd
00:10:00
Navigating Leadership and Innovation: A Conversation with Angi CEO Oisin Hanrahan | Oisin Hanrahan, CEO, Angi Inc.

© 2026 Nehu